FINWIRES · TerminalLIVE
FINWIRES

Update: Life360 Posts Lower Q1 Earnings, Higher Revenue; Raises 2026 Outlook, Shares Fall 11%

By

(Updates to add stock movement in the headline and last paragraph)

Life360 (ASX:360) reported Tuesday first-quarter earnings of $0.03 per share, down from $0.05 a year earlier.

Analysts polled by FactSet expected the company to break even.

Revenue for the three months ended March 31 was $143.1 million, compared with $103.6 million a year earlier. Analysts surveyed by FactSet expected $137 million.

The company raised its 2026 guidance, now expecting consolidated revenue of $650 million to $685 million, up from the previous range of $640 million to $680 million, and adjusted earnings before interest, taxes, depreciation, and amortization of $130 million to $140 million, compared with prior guidance of $128 million to $138 million. Analysts surveyed by FactSet expect sales of $663.5 million.

The company's shares fell around 11% in recent Tuesday trade.

Related Articles

Asia

Shandong Yisheng Livestock & Poultry Breeding's Broiler Chick, Pig Sales Rise in April

Shandong Yisheng Livestock & Poultry Breeding's (SHE:002458) broiler chick sales revenue jumped 55% to 219 million yuan in April, according to a Tuesday filing with the Shenzhen bourse.Sales volume grew 13 to 55.3 million broiler chicks.Its Yisheng 909 mini broiler chicks saw sales revenue of 12.8 million yuan, up 104% year over year, while its sales volume jumped 19% to 8.2 million.Breeding pig sales revenue surged 325% to 40.4 million yuan while sales volume expanded 478% to 19,521 breeding pigs.

$SHE:002458
Asia

Trendlines, Controlling Shareholder to Invest Combined $1.4 Million in Portfolio Firms

Trendlines Group (SGX:42T) said its board approved a capital injection into portfolio companies Ceretrieve and Vensica Medical by controlling shareholder Librae Holdings.Shares of the agrifood and med-tech company were down over 1% in Tuesday's afternoon trade.Librae will invest around $850,000 in the units. Additionally, Trendlines will infuse a total of $550,000 to the portfolio firms, according to a Monday filing with the Singapore Exchange.The funding is aimed at supporting the ongoing operations of the portfolio companies and helping them achieve successful exits, the filing said.Ceretrieve develops neurointerventional devices, while Vensica Medical specializes in bladder-targeted therapies.

$SGX:42T
Asia

Galaxy Entertainment Revenue Rises 11% in Q1 2026

Galaxy Entertainment Group (HKG:0027) reported HK$12.4 billion in first quarter 2026 revenue, up 11% from HK$11.20 billion a year earlier, according to a Tuesday filing with the Hong Kong bourse.Revenue from the gaming business increased to HK$10.02 billion from HK$8.92 billion in the prior year. Non-gaming revenue stood at HK$1.71 billion, rising from HK$1.56 billion, while sales from construction materials fell to HK$666 million from HK$723 million, figures showed.

$HKG:0027